Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People
Irritability
Clinical Dementia Rating
Mini–Mental State Examination
Posterior cingulate
DOI:
10.3233/jad-150181
Publication Date:
2015-11-27T13:35:17Z
AUTHORS (10)
ABSTRACT
Background: Neuropsychiatric symptoms, also known as behavioral and psychological symptoms of dementia (BPSD), affect the majority patients with dementia, result in a greater cognitive functional impairment. Objective: To investigate associations between BPSD amyloid cerebral deposition measured by 18F-Florbetapir-PET quantitative uptake elderly subjects without Methods: Participants impairment [mild (MCI) or Alzheimer’s disease (AD)] healthy controls (HC) from ADNI cohort (Alzheimer Disease Neuroimaging Initiative) who underwent an 18F-florbetapir PET scan May 2010 March 2014 were included. Clinical assessments included Dementia Rating, Mini-Mental State Examination (MMSE), Inventory. Freesurfer software was used to extract counts based on T1-based structural ROI (frontal, cingulate, parietal, temporal). Spearman’s partial correlation scores severity regional calculated. Results: Data for 657 participants [age = 72.6 (7.19); MMSE 27.4 (2.67)] analyzed, including 230 HC 73.1 (6.02); 29 (1.21)], 308 MCI 71.5 (7.44); 28.0 (1.75)], 119 AD 74.7 (8.05); 23.1 (2.08)]. Considering all diagnostic groups together, positive significant correlations found anxiety frontal (r 0.102; p 0.009), cingulate 0.083; 0.034), global 0.099; 0.011); irritability 0.089; 0.023), 0.085; 0.030), parietal 0.087; 0.025), 0.093; 0.017); subgroup, 0.126; 0.03) 0.14; 0.013); 0.201; 0.03). Conclusion: Anxiety are associated neurodegenerative process leading AD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (53)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....